Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells. (Q40038897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

Corrigendum to “Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells” [FEBS Lett. 581 (2007) 5897-5903]

29 December 2019

main subject

multiple drug resistance

1 reference

1 reference

1 reference

corrigendum / erratum

0 references

author

Rosa Vona

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Paola Matarrese

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Roberto Cauda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Walter Malorni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

9

Elisabetta Straface

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

4

Barbara Ascione

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

7

Lucio Gnessi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

5

Stefania Mariani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

Sabrina Basciani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Mothanje Barbara Lucia

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

3 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

5897-5903

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061581%20AND%20SRC:MED&resulttype=core&format=json

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Role of KIT and platelet-derived growth factor receptors as oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Imatinib-induced regression of AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Biology of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Down-regulation of bcr-abl and bcl-x(L) expression in a leukemia cell line and its doxorubicin-resistant variant by topoisomerase II inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

The tyrosine kinase inhibitors imatinib and AG957 reverse multidrug resistance in a chronic myelogenous leukemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Double identity for proteins of the Bcl-2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Regulation and role of autophagy in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069

Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.11.069